Sectors
Where the money is
Tracked capital by sector for Q2 2026: $3.88T across 92 managers. Unclassified: 1.2% ⓘSecurities we could not match to an operating company sector (mostly bonds, warrants, foreign listings without an SEC filing).
Sector allocation
Q2 2026 · click a sector to see its stocks
Sectors
- Information Technology 25.7%$998.13B · 763 stocks
- Financials 16.8%$650.90B · 1295 stocks
- Industrials 12.5%$486.37B · 743 stocks
- Health Care 8.7%$339.35B · 896 stocks
- Consumer Discretionary 8.2%$317.26B · 484 stocks
- Communication Services 7.5%$289.84B · 134 stocks
- Consumer Staples 4.9%$189.43B · 161 stocks
- Materials 3.8%$145.97B · 337 stocks
- Energy 3.4%$132.87B · 174 stocks
- ETFs & Funds 2.9%$111.18B · 2573 stocks
- Real Estate 2.4%$94.03B · 230 stocks
- Utilities 2.0%$77.63B · 143 stocks
- Unclassified 1.2%$47.06B · 457 stocks
Sector rotation: where money moved in Q2 2026
Est. net buying by sector (managers that filed both quarters), and each sector's share of tracked capital now vs. Q1 2026. ⓘEst. net buying: For each manager, the change in shares × this quarter's price, added up across all managers. A positive number means more shares were bought than sold. Price moves alone never count. Guide Weight changes also reflect price moves.
| Sector | Est. net buying | New / sold out | Weight now | Q1 '26 | Change |
|---|---|---|---|---|---|
| Information Technology | +$12.23B | 919 / 613 | 25.7% | 19.4% | +6.3 pts |
| Financials | -$911.90M | 1056 / 766 | 16.8% | 18.3% | -1.6 pts |
| Industrials | +$14.62B | 745 / 598 | 12.5% | 13.2% | -0.7 pts |
| Health Care | +$7.73B | 833 / 677 | 8.7% | 9.1% | -0.4 pts |
| Consumer Discretionary | +$12.35B | 417 / 386 | 8.2% | 8.1% | +0.1 pts |
| Communication Services | +$16.23B | 115 / 113 | 7.5% | 6.8% | +0.7 pts |
| Consumer Staples | +$4.66B | 144 / 125 | 4.9% | 5.5% | -0.6 pts |
| Materials | -$487.44M | 279 / 267 | 3.8% | 4.5% | -0.7 pts |
| Energy | -$7.20B | 149 / 116 | 3.4% | 5.7% | -2.3 pts |
| ETFs & Funds | +$23.22B | 1567 / 1274 | 2.9% | 3.3% | -0.4 pts |
| Real Estate | -$1.87B | 172 / 192 | 2.4% | 2.1% | +0.3 pts |
| Utilities | +$1.19B | 118 / 110 | 2.0% | 2.1% | -0.1 pts |
| Unclassified | -$9.59B | 311 / 645 | 1.2% | 1.9% | -0.7 pts |
Sector weights over time
% of tracked capital in each sector, full quarters
Top stocks in Health Care
Sort by Est. net buying to see where money moved this quarter, not just where it sits.
Column filters
| Ticker | Company | Est. net buying ⓘFor each manager, the change in shares × this quarter's price, added up across all managers. A positive number means more shares were bought than sold. Price moves alone never count. | Buying | Selling | Managers | Total value ↓ | Avg. weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value). |
|---|---|---|---|---|---|---|---|
| LLY | ELI Lilly & Co | +$218.90M | 13 | 12 | 27 | $25.09B | 0.8% |
| UNH | Unitedhealth Group Inc | -$311.15M | 17 | 19 | 34 | $18.77B | 1.0% |
| MRK | Merck & Co., Inc | +$700.99M | 6 | 17 | 25 | $15.64B | 0.9% |
| JNJ | Johnson & Johnson | +$483.67M | 7 | 18 | 30 | $15.40B | 0.7% |
| ABBV | AbbVie Inc | +$1.83B | 11 | 7 | 19 | $12.10B | 0.5% |
| AZN | Astrazeneca plc | +$352.01M | 6 | 8 | 15 | $11.70B | 1.5% |
| GILD | Gilead Sciences, Inc | +$599.23M | 8 | 8 | 18 | $8.37B | 0.3% |
| ISRG | Intuitive Surgical Inc | -$665.52M | 8 | 12 | 20 | $7.72B | 0.7% |
| DVA | Davita Inc | -$409.59M | 2 | 7 | 9 | $6.92B | 0.3% |
| GEHC | GE HealthCare Technologies Inc | +$1.12B | 14 | 6 | 20 | $6.60B | 0.8% |
| MDT | Medtronic plc | +$1.55B | 13 | 7 | 21 | $6.21B | 0.6% |
| ABT | Abbott Laboratories | +$1.03B | 8 | 12 | 24 | $6.18B | 0.6% |
| PFE | Pfizer Inc | -$215.15M | 13 | 9 | 23 | $5.56B | 0.5% |
| GSK | GSK plc | -$308.14M | 9 | 8 | 16 | $5.09B | 0.3% |
| REGN | Regeneron Pharmaceuticals, Inc | +$347.26M | 10 | 6 | 14 | $4.90B | 0.7% |
| BDX | Becton Dickinson & Co | +$1.09B | 9 | 9 | 15 | $4.87B | 1.5% |
| AMGN | Amgen Inc | +$947.94M | 8 | 6 | 15 | $4.69B | 0.7% |
| BMY | Bristol Myers Squibb Co | -$719.03M | 8 | 11 | 18 | $4.52B | 0.4% |
| ZBH | Zimmer Biomet Holdings, Inc | +$305.18M | 10 | 7 | 17 | $4.19B | 0.4% |
| IQV | Iqvia Holdings Inc | +$316.39M | 7 | 3 | 13 | $4.12B | 0.5% |
| MCK | McKesson Corp | +$679.82M | 11 | 5 | 16 | $3.65B | 0.3% |
| COR | Cencora, Inc | +$714.34M | 9 | 2 | 13 | $3.52B | 0.5% |
| BSX | Boston Scientific Corp | -$44.14M | 9 | 11 | 18 | $3.51B | 0.1% |
| ICLR | Icon plc | +$318.91M | 8 | 9 | 16 | $3.39B | 1.8% |
| NTRA | Natera, Inc | +$289.29M | 9 | 7 | 16 | $3.38B | 1.6% |
| BAX | Baxter International Inc | -$2.81M | 6 | 5 | 12 | $3.29B | 0.9% |
| ALNY | Alnylam Pharmaceuticals, Inc | -$37.43M | 4 | 5 | 10 | $3.09B | 0.2% |
| NVS | Novartis AG | -$617.97M | 7 | 9 | 17 | $2.98B | 0.2% |
| HCA | HCA Healthcare, Inc | -$518.43M | 10 | 10 | 18 | $2.96B | 0.3% |
| SYK | Stryker Corp | +$79.41M | 4 | 9 | 13 | $2.95B | 0.2% |
| MMM | 3M Co | -$23.12M | 5 | 8 | 14 | $2.88B | 0.1% |
| INCY | Incyte Corp | +$139.49M | 6 | 7 | 13 | $2.76B | 0.4% |
| MDLN | Medline Inc (Class A) | +$210.37M | 7 | 8 | 13 | $2.76B | 1.1% |
| VRTX | Vertex Pharmaceuticals Inc / Ma | +$115.85M | 5 | 8 | 14 | $2.45B | 0.2% |
| SNY | Sanofi | -$139.02M | 8 | 4 | 12 | $2.44B | 0.3% |
| LH | Labcorp Holdings Inc | +$84.97M | 5 | 8 | 14 | $2.30B | 0.5% |
| UTHR | United Therapeutics Corp | -$24.13M | 5 | 8 | 14 | $2.29B | 0.2% |
| NVO | Novo Nordisk A S | -$123.85M | 6 | 8 | 14 | $2.20B | 0.3% |
| MRNA | Moderna, Inc | -$274.08M | 3 | 8 | 10 | $2.19B | 0.2% |
| BMRN | Biomarin Pharmaceutical Inc | -$274.24M | 5 | 11 | 15 | $2.08B | 0.2% |
| DGX | Quest Diagnostics Inc | +$64.89M | 5 | 5 | 12 | $2.08B | 0.3% |
| GH | Guardant Health, Inc | -$11.43M | 5 | 7 | 12 | $2.07B | 0.2% |
| BBIO | BridgeBio Pharma, Inc | +$243.86M | 6 | 6 | 13 | $2.06B | 0.3% |
| EW | Edwards Lifesciences Corp | +$508.44M | 8 | 6 | 15 | $2.06B | 0.5% |
| ELAN | Elanco Animal Health Inc | +$44.51M | 4 | 6 | 10 | $2.05B | 0.2% |
| IDXX | Idexx Laboratories Inc | +$365.69M | 8 | 10 | 15 | $2.05B | 0.7% |
| THC | Tenet Healthcare Corp | +$84.87M | 9 | 4 | 14 | $2.01B | 0.7% |
| SOLV | Solventum Corp | +$22.35M | 8 | 6 | 16 | $1.98B | 1.2% |
| EXEL | Exelixis, Inc | +$191.14M | 5 | 5 | 11 | $1.96B | 0.2% |
| NBIX | Neurocrine Biosciences Inc | -$369.14M | 5 | 6 | 11 | $1.93B | 0.1% |
Politician trades by sector
Politician trades by sector
Stock trades only. Sector comes from the matching 13F security where we could match one.
Column filters
| Sector | Trades ↓ | Purchases | Sales | Est. volume ⓘEstimate only: sum of the midpoints of the reported dollar ranges. |
|---|---|---|---|---|
| Information Technology | 2,997 | 1,673 | 1,299 | $411.67M |
| Industrials | 1,891 | 929 | 952 | $80.86M |
| Financials | 1,771 | 889 | 870 | $25.01M |
| Health Care | 1,421 | 724 | 688 | $18.62M |
| Consumer Discretionary | 1,324 | 671 | 643 | $53.57M |
| Consumer Staples | 989 | 511 | 475 | $26.66M |
| Materials | 673 | 351 | 311 | $44.70M |
| Communication Services | 507 | 271 | 229 | $18.65M |
| Unclassified | 441 | 190 | 238 | $5.03M |
| Real Estate | 417 | 221 | 195 | $19.46M |
| Utilities | 258 | 122 | 132 | $4.00M |
| Energy | 146 | 61 | 82 | $2.51M |
| ETFs & Funds | 27 | 14 | 13 | $355.01K |
Column filters
| Ticker | Company | Sector | Trades ↓ | Politicians | Purchases | Sales | Est. net buying ⓘEstimate only: purchases minus sales using the midpoint of each reported dollar range. | Last trade |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Health Care | 71 | 10 | 47 | 23 | -$988 | Sep 8, 2026 |
| ZTS | Zoetis Inc (Class A) | Health Care | 64 | 6 | 33 | 31 | -$25.00K | Sep 18, 2026 |
| ABT | Abbott Laboratories | Health Care | 60 | 8 | 21 | 36 | -$103.51K | Sep 18, 2026 |
| LLY | ELI Lilly & Co | Health Care | 54 | 9 | 19 | 35 | -$110.01K | Sep 4, 2026 |
| ISRG | Intuitive Surgical Inc | Health Care | 52 | 5 | 26 | 25 | +$8.00K | Sep 11, 2026 |
| MRK | Merck & Co., Inc | Health Care | 52 | 9 | 26 | 26 | -$98.00K | Jun 2, 2026 |
| BAX | Baxter International Inc | Health Care | 47 | 2 | 19 | 28 | -$96.50K | May 27, 2026 |
| PFE | Pfizer Inc | Health Care | 46 | 6 | 21 | 25 | -$195.00K | Sep 4, 2026 |
| ABBV | AbbVie Inc | Health Care | 44 | 6 | 22 | 21 | +$32.50K | Sep 4, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc | Health Care | 43 | 6 | 14 | 27 | -$128.51K | Sep 4, 2026 |
| UNH | Unitedhealth Group Inc | Health Care | 40 | 9 | 15 | 25 | -$104.50K | Apr 14, 2026 |
| BSX | Boston Scientific Corp | Health Care | 39 | 3 | 20 | 19 | +$32.50K | Sep 11, 2026 |
| COO | Cooper Companies, Inc | Health Care | 39 | 2 | 31 | 8 | +$184.01K | Sep 17, 2026 |
| MCK | McKesson Corp | Health Care | 39 | 9 | 21 | 18 | +$7.50K | Sep 4, 2026 |
| SYK | Stryker Corp | Health Care | 35 | 4 | 17 | 18 | -$81.50K | Jun 30, 2026 |